Related Experiment Videos
Carcinoma of prostatic ducts
C D Vera-Donoso1, J Vidal, S Gómez
1Service of Urology, La Fé Hospital, Valencia, Spain.
European Urology
|January 1, 1991
Summary
Prostatic ductal carcinoma is rare, found in 2.51% of cases. This cancer type has a poorer prognosis than acinar carcinoma, emphasizing the need for early diagnosis and treatment.
Area of Science:
- Urology
- Oncology
- Pathology
Background:
- Carcinoma of prostatic ducts is an uncommon finding.
- Prostatic ductal carcinoma represents a rare subtype of prostate cancer.
Purpose of the Study:
- To investigate the clinical characteristics, prognosis, and treatment outcomes of prostatic ductal carcinoma.
- To compare prostatic ductal carcinoma with the more common acinar adenocarcinoma.
Main Methods:
- Retrospective review of 398 patient histories with prostatic carcinoma.
- Histological analysis to identify ductal carcinoma subtypes (pure ductal transitional cell carcinoma, mixed acinar and ductal adenocarcinoma).
- Comparison of clinical presentation, imaging, and survival data with acinar carcinoma.
Main Results:
- Prostatic ductal carcinoma was identified in 10 patients (2.51%).
- Histological subtypes included pure ductal transitional cell carcinoma and mixed forms.
- Clinical presentation and imaging findings were similar to acinar carcinoma, but mean survival was significantly lower (23 months).
Conclusions:
- Prostatic ductal carcinoma, despite similar initial presentation to acinar carcinoma, has a poorer prognosis.
- Early diagnosis and radical surgical intervention are crucial for improving survival rates in patients with prostatic ductal carcinoma.